97 related articles for article (PubMed ID: 9404948)
1. U-50,488H, a selective kappa opioid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice.
Hiramatsu M; Hyodo T; Kameyama T
Neurosci Lett; 1997 Oct; 236(1):45-8. PubMed ID: 9404948
[TBL] [Abstract][Full Text] [Related]
2. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
Hiramatsu M; Murasawa H; Mori H; Kameyama T
Br J Pharmacol; 1998 Mar; 123(5):920-6. PubMed ID: 9535021
[TBL] [Abstract][Full Text] [Related]
3. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
4. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
Hiramatsu M; Kameyama T
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
[TBL] [Abstract][Full Text] [Related]
5. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
6. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice.
Itoh J; Ukai M; Kameyama T
Brain Res; 1993 Aug; 619(1-2):223-8. PubMed ID: 8397052
[TBL] [Abstract][Full Text] [Related]
7. Kappa Opioid Receptor Agonist Administration in Olfactory Bulbectomized Mice Restores Cognitive Impairment through Cholinergic Neuron Activation.
Takahashi K; Nakagawasai O; Sugawara M; Sato A; Nemoto W; Tadano T; Tan-No K
Biol Pharm Bull; 2018; 41(6):957-960. PubMed ID: 29863085
[TBL] [Abstract][Full Text] [Related]
8. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
[TBL] [Abstract][Full Text] [Related]
9. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
10. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice.
Hiramatsu M; Hyodo T; Kameyama T
Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.
Ukai M; Shan-Wu X; Kobayashi T; Kameyama T
Eur J Pharmacol; 1996 Oct; 313(1-2):11-5. PubMed ID: 8905323
[TBL] [Abstract][Full Text] [Related]
13. kappa-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1995 Aug; 281(2):173-8. PubMed ID: 7589204
[TBL] [Abstract][Full Text] [Related]
14. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
Ukai M; Suzuki M; Mamiya T
J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific effects of the selective kappa-opioid receptor agonist U-50,488H on dopamine uptake and release in PC12 cells.
Chudapongse N; Kim SY; Kramer RE; Ho IK
J Pharmacol Sci; 2003 Nov; 93(3):372-5. PubMed ID: 14646257
[TBL] [Abstract][Full Text] [Related]
16. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
17. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
[TBL] [Abstract][Full Text] [Related]
18. Involvement of kappa-opioid and sigma receptors in short-term memory in mice.
Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T
Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064
[TBL] [Abstract][Full Text] [Related]
19. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats.
Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T
Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822
[TBL] [Abstract][Full Text] [Related]
20. The amygdala mediates the impairing effect of the selective kappa-opioid receptor agonist U-50,488 on memory in CD1 mice.
Castellano C; Libri V; Ammassari-Teule M
Behav Brain Res; 1988 Oct; 30(3):259-63. PubMed ID: 2846004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
